These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 3070430)
1. [Use of Orthoclone OKT3 in salvage treatment of primary acute renal allograft rejection resistant to steroids and antilymphocyte globulins]. Guérin C; Daoud M; Paysant B; Sabatier JC; Berthoux P; Berthoux F Nephrologie; 1988; 9(6):282-3. PubMed ID: 3070430 [No Abstract] [Full Text] [Related]
2. The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin. Davies SP; Brown EA; Woodrow DF; Phillips ME; Gower PE; Mee AD Transplantation; 1991 Oct; 52(4):746-9. PubMed ID: 1926361 [No Abstract] [Full Text] [Related]
3. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody. McLigeyo SO; Notghi A; Anderton JL; Dick J East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786 [TBL] [Abstract][Full Text] [Related]
4. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A. Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454 [No Abstract] [Full Text] [Related]
8. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation. Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183 [No Abstract] [Full Text] [Related]
9. [Neurologic complications induced by the treatment of the acute renal allograft rejection with the monoclonal antibody OKT3]. Fernández O; Romero F; Bravo M; Burgos D; Cabello M; González-Molina M Neurologia; 1993 Oct; 8(8):277-80. PubMed ID: 8240843 [TBL] [Abstract][Full Text] [Related]
10. Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation. Winde G; Dietl KH; Raidt H; Buchholz B; Lison AE; Bünte H Transplant Proc; 1988 Oct; 20(5 Suppl 6):87-9. PubMed ID: 3140453 [No Abstract] [Full Text] [Related]
18. Proceedings of an international symposium on monoclonal antibody therapy with orthoclone OKT3 in renal transplantation. Transplant Proc; 1986 Aug; 18(4):923-56. PubMed ID: 3526665 [No Abstract] [Full Text] [Related]
19. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts. Alamartine E; Bellakoul R; Berthoux F Transplant Proc; 1994 Feb; 26(1):273-4. PubMed ID: 8108975 [No Abstract] [Full Text] [Related]
20. [Treatment of kidney graft rejection with a monoclonal antibody (Orthoclone OKT-3)]. Ladefoged SD; Friedberg M; Glenthøj A Ugeskr Laeger; 1988 Nov; 150(48):2974-6. PubMed ID: 3144080 [No Abstract] [Full Text] [Related] [Next] [New Search]